(Health-NewsWire.Net, May 21, 2018 ) According to Publisher, the Global Nephrology and Urology Devices is valued at $17.28 billion in 2015 and is expected to grow at a CAGR of 7.2% to reach $28.27 billion by 2022. Rising occurrence of chronic kidney diseases, increased spending on healthcare among the emerging regions and growing aged population across the world are some of the factors favoring the market growth. Moreover, the growing awareness about the benefits of these devices such as abridged recovery and treatment time is also propelling the global market. On the other hand, the high cost linked with these devices hampers the market.
For more information http://www.reportsweb.com/nephrology-and-urology-devices-global-market-outlook-2015-2022
Dialysis devices commanded the largest market share and BPH treatment devices are anticipated to witness the fastest growth during the forecast period. Fresenius was leading the market in dialysis devices followed Baxter Corporation. Benign Prostatic Hyperplasia is a major concern and is expected to affect around 75% of male over the age of 55, thus driving the market to grow. Regionally, Europe is presently leading the market owing to the increasing need to keep up with the infrastructural requirements in hospital in region. Asia-Pacific is expected to grow at a faster pace due to the promising medical tourism industry in the region. New Product launch, merger and acquisition, and research and development are the successful strategies followed by the players in the market to gain the traction.
Some of the key players in global Nephrology and Urology Devices market are Nikkiso Co. Ltd., Boston Scientific, American Medical Systems, LLC, Cook Medical, Olympus Medical Systems, Asahi Kasei Corporation, Rockwell Medical Technologies Inc., Dornier MedTech, Coloplast, Terumo Corporation, Fresenius Medical Care, B Braun Group, Nipro Corporation, Baxter International Inc., NxStage Medical, Inc. and C. R. Bard, Inc.,.
-Benign Prostatic Hyperplasia Devices
-Urinary Stone Treatment
-Urinary Incontinence Devices
-Erectile Dysfunction Device
-Pelvic Floor Repair
-Ureteral Access Devices
Type of Diseases Covered:
-Urinary Incontinence (UI) and Pelvic Organ Prolapsed (POP)
-Percutaneous Nephrostolithotomy (PCNL)
-Extra-Corporeal Shock Wave Lithotripsy (ESWL)
-Benign Prostatic Hyperplasia (BPH)
-Holmium Laser Enucleation of Prostate (HOLEP)
-Transurethral Radio Frequency Needle Ablation of the Prostate (TUNA)
-Stenting (Prostatic Stents)
-Surgery for BPH
-Transurethral Microwave Thermotherapy of the Prostate (TUMT)
-Chronic Kidney Disease And Renal Failure
End Users Covered:
-Hospitals and Clinics
-Ambulatory Surgical Centers (ASC)
-Other End Users
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001322827/sample
-Rest of Europe
-Rest of Asia Pacific
-Rest of the World
10 Company Profiling
10.1 Nikkiso Co. Ltd.
10.2 Boston Scientific
10.3 American Medical Systems, LLC
10.4 Cook Medical
10.5 Olympus Medical Systems
10.6 Asahi Kasei Corporation
10.7 Rockwell Medical Technologies Inc.
10.8 Dornier MedTech
10.10 Terumo Corporation
10.11 Fresenius Medical Care
10.12 B Braun Group
10.13 Nipro Corporation
10.14 Baxter International Inc.
10.15 NxStage Medical, Inc.
10.16 C. R. Bard, Inc.,
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001322827/buying